NGM Biopharmaceuticals: Q4 Earnings Snapshot
NGM Biopharmaceuticals: Q3 Earnings Snapshot
NGM Biopharmaceuticals: Q2 Earnings Snapshot
NGM Biopharmaceuticals: Q1 Earnings Snapshot
NGM Biopharmaceuticals: Q4 Earnings Snapshot
Belharra Therapeutics, Inc. today emerged from stealth mode with a novel photoaffinity-based chemoproteomics platform capable of identifying non-covalent, small molecule drug candidates for any protein....
NGM Biopharmaceuticals: Q3 Earnings Snapshot
NEW YORK (AP) — Stocks that traded heavily or had substantial price changes Monday:
--NGM621, a monoclonal antibody product candidate engineered to potently inhibit complement C3 for the treatment of patients with geographic atrophy, will...
SOUTH SAN FRANCISCO, Calif., June 02, 2022 (GLOBE NEWSWIRE) -- NGM Biopharmaceuticals, Inc. (NGM Bio) (Nasdaq: NGM), a biotechnology company focused on...